In February 2025, Nimbus announced progress in that partnership, namely the discovery of what it termed a highly selective isoform-specific AMPK activator
Inhibition of glutathione metabolism by BSO decreased the ESCC tumor burden To investigate whether glutathione metabolism contributed to the progression of ESCC development, we treated mice bearing ESCC 20 weeks after initial carcinogen treatment with buthionine sulfoximine (BSO), a commonly used chemical inhibitor of -glutamylcysteine synthetase (-GCS) that decreases tissue glutathione concentrations (Figure 3a)
If your primary concern is blood sugar management and diabetes care, Ozempic may be the preferred choice
To maximize its benefits, pair L-Carnitine supplementation with lifestyle adjustments such as maintaining a balanced diet, engaging in regular exercise, and managing your weight
As we move forward, the emphasis on patient safety, informed consent, and the t herapeutic alliance will guide us through the benefits and risks of emerging treatments in an informed and ethical manner